Accuracy of Deep Inferior Epigastric Artery Perforator Mapping - Color Doppler Ultrasound Versus CT Angiography

NCT ID: NCT05687006

Last Updated: 2023-01-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-01

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to compare the accuracy and contribution of Color Doppler Ultrasound (CDU) guided Deep Inferior Epigastric Artery (DIEA) perforator mapping with or without mapping using Computer Tomography angiography (CTA) in women over 18 years undergoing 2021 unilateral or bilateral breast reconstruction with an abdominal free flap.

Participants underwent scheduled reconstruction of one or both breasts with a free flap transferred from the lower abdomen. If there is a comparison group: Researchers compared interventional groups - examined using preoperative CTA of the abdominal wall supplemented with an examination of the perforators using CDU (active comparator group), and examined exclusively by using the CDU (experimental group), to see the comparison of the accuracy and contribution of CDU-guided DIEA perforator mapping with CTA mapping.

The hypothesis is that CDU examination alone is not inferior to CTA examination supplemented with parameters that CTA does not show (flow velocity, vessel diameters), by measuring these parameters with CDU.

The main questions it aims to answer are:

* To evaluate the comparison of the accuracy of surgeon-conducted CDU perforator mapping in defining the significant/dominant perforators and their exact location \[XY coordinates\] with the accuracy of CTA mapping.
* To compare the time duration of the CDU examination was measured.
* To measure the Fat Necrosis of the flap \[3 months postoperative \]
* To measure the Flap Loss \[1-week post-op, 2 weeks post-op, 6-8 weeks post-op and 3 months post-op\].

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A blinded, randomized, prospective clinical trial was performed involving women over 18 years undergoing 2021 unilateral or bilateral breast reconstruction with an abdominal free flap. The inclusion of the mapping of major perforators as a part of preoperative deep inferior epigastric perforator (DIEP) flap planning reduces the operating time and complication rate. According to recent meta-analyses computed tomographic angiography (CTA) brings the most advantages; however, only a few studies comprising colour Doppler ultrasonography (CDU) were included with several biases in addition. Especially, studies directly comparing CTA and CDU (surgeons conducted in one study only, in one case) are rare. Recently, CDU has seen significant advances in quality and imaging capabilities, and ultrasound devices are widely available.

Women were originally randomized 1:1 to the groups one of which will undergo only CDU perforator mapping (experimental group) and the other using CTA+CDU (active comparator group). Every patient included in the CTA+CDU group preoperatively underwent CT angiography of the abdominal wall. Based on the CTA examination XY coordinates of DIEA perforators with a vessel calibre of 1 mm were determined.

The velocity and vessel diameters of these perforators were additionally examined using a CDU device. Any additional perforators were marked, nor were CTA deducted XY coordinates of marked perforators changed, based on the CDU examination. The same sonography surgeon performed all CDU examinations.

All patients included in the CDU group were examined with the same CDU device by the same sonography surgeon as patients included in CTA + CDU group. During the examination, DIEA perforators were mapped and those with a vessel calibre of 1 mm were marked and XY coordinates deducted. Calibres and velocities of perforator vessels and the abdominal subcutaneous tissue thickness were measured.

In the CTA+CDU group, CDU was used only to determine the additional parameters necessary to define categories 1-3 (according to the number of perforators). Based on CDU, coordinates were not measured in the CTA+CDU group. The main aim of this clinical study is to compare the accuracy of perforator localization (coordinates) using CDU vs. CTA.

Based on the preoperative mapping, all patients in both groups were assigned a category for each flap as follows:

A) At least one perforator of the flap meets the criteria defined for a dominant perforator. In such a case, the tactic was to dissect a single perforator flap.

B) Any perforator meets the criteria defined for a dominant perforator, but at least two perforators on the same DIEA branch meet the criteria for a significant perforator. In such a case, the tactic was to dissect the flap with the pedicle of two of those perforators.

C) Any perforator meets the criteria defined for a dominant perforator or significant perforator. In such a case, the surgical tactic was to dissect the flap with a pedicle of three perforators or as an MS-TRAM flap.

The operating surgeon was fully informed of the results of the preoperative examination and the recommended perforator or perforator selected for the flap's pedicle. However, these recommendations were not binding, and the surgeon chose the tactics of the operation taking into consideration his clinical experience. Participating in the project did not change the surgical technique and the surgery was performed as standard according to current knowledge of medicine and common practice of the department. The surgery itself was not the subject of the research. XY coordinates and diameters of the dissected perforators were measured during the surgery.

R 4.1.3 software and Joinpoint Regression 4.9.0.0. were used to perform data management and exploratory statistical analysis (p = 0.05). A two-sided Wilcoxon test was used for verification of both patient groups' comparability. The same test was used to compare the length of the CDU examination in both groups. The breaking point on the curve showing the length of the CDU examination depending on the numerical order of the examined patient was searched using the Joinpoint Regression as a secondary outcome. Euclidean distance was used to determine the difference between the CDU/CTA and during the surgery measured coordinates of the dissected perforators. Statistical testing of the difference between the accuracy of CTA and CDU examinations was performed using the GLS method. The GEE model was used to determine the difference between the CDU/CTA+CDU recommended and finally dissected a number of perforators supplying the flap.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mammaplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomization was carried out using an envelope method, during which the patients were randomly assigned in a ratio 1:1 to an active comparator group: "CTA+CDU (preoperative examination of vascular anatomy by CTA supplemented with vessel calibre examination of the perforator using CDU)" or an experimental group: "CDU (preoperative examination of vascular anatomy by colour duplex sonography only)".
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The CTA+CDU Group

Every patient included in the CTA+CDU group preoperatively underwent CT angiography of the abdominal wall. Based on the CTA examination XY coordinates of DIEA perforators localized within the area between 2 cm cranial and 10 cm caudal from the umbilicus and with a vessel calibre of more than 1 mm were determined. The day before the surgery, the main perforators were marked on the patient's abdomen according to the coordinates deducted from the CTA. These perforators were additionally examined using a LOGIQ S8/V1 CDU device with a linear transducer of frequency 4-11 MHz. Any additional perforators were marked nor have CTA deducted XY coordinates of marked perforators changed based on the CDU examination. The same sonography surgeon performed all CDU examinations. The time duration of the CDU examination was measured.

Group Type NO_INTERVENTION

No interventions assigned to this group

The CDU Group

All patients included in the CDU group were examined a day before the surgery with the same CDU device by the same sonography surgeon as patients included in CTA + CDU group. During the examination, DIEA perforators were mapped and the following parameters were monitored: 1) XY coordinates of DIEA perforators localized within the area between 2 cm cranial and 10 cm caudal from the umbilicus and with a vessel calibre of more than 1 mm; 2) calibres of perforator arteries and veins; 3) PSV in the perforator artery \[cm/s\]; 4) velocity in the perforator vein \[cm/s\]; 5) the thickness of the subcutaneous tissue of the lower abdomen measured 4 cm caudal and lateral to the umbilicus. The time duration of the CDU examination was measured.

Group Type EXPERIMENTAL

Colour Doppler Ultrasound

Intervention Type PROCEDURE

The main perforators were examined using a LOGIQ S8/V1 CDU device (GE Healthcare, Chalfont St Giles, Great Britain) with a linear transducer of frequency 4-11 MHz. Measured parameters were: 1) calibre of artery and vein; 2) Peak systolic velocity (PSV) of blood in the artery \[cm/s\]; 3) blood velocity in the perforator vein \[cm/s\]; 2) the thickness of the subcutaneous tissue of the lower abdomen measured 4 cm caudal and lateral to the umbilicus. Any additional perforators were marked nor have CTA deducted XY coordinates of marked perforators changed based on the CDU examination. The same sonography surgeon performed all CDU examinations. The time duration of the CDU examination was measured.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Colour Doppler Ultrasound

The main perforators were examined using a LOGIQ S8/V1 CDU device (GE Healthcare, Chalfont St Giles, Great Britain) with a linear transducer of frequency 4-11 MHz. Measured parameters were: 1) calibre of artery and vein; 2) Peak systolic velocity (PSV) of blood in the artery \[cm/s\]; 3) blood velocity in the perforator vein \[cm/s\]; 2) the thickness of the subcutaneous tissue of the lower abdomen measured 4 cm caudal and lateral to the umbilicus. Any additional perforators were marked nor have CTA deducted XY coordinates of marked perforators changed based on the CDU examination. The same sonography surgeon performed all CDU examinations. The time duration of the CDU examination was measured.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

CDU

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* female;
* aged 18 to 65 years;
* undergoing uni- or bilateral breast free flap reconstruction harvested from the lower abdomen;
* signed informed consent to participate in the study.

Exclusion Criteria

* history of allergy to iodinated contrast material;
* history of abdominoplasty;
* Body Mass index \> 35;
* active oncological disease ;
* Karnofsky Performance Status \< 50;
* change of the reconstructive method as a result of the preoperative mapping;
* non-standard performed CTA examination.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Masaryk University

OTHER

Sponsor Role collaborator

St. Anne's University Hospital Brno, Czech Republic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Libor Streit, MD, PhD.

Role: PRINCIPAL_INVESTIGATOR

St. Anne´s University Hospital Brno

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Anne´s University Hospital Brno

Brno, , Czechia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CDU2021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Using Diagnostic Tools to Stage Breast Cancer
NCT00367666 ACTIVE_NOT_RECRUITING NA